Skip to main content

Table 3 Comparison of indicators between pregnant group and non-pregnant group in PCOS patients

From: Differential expression of serum mir-363-3p in patients with polycystic ovary syndrome and its predictive value for their pregnancy

Indicators

Pregnancy group

(n = 70)

Non-pregnancy group

(n = 56)

P value

Age (Year)

28.39 ± 2.41

28.31 ± 2.49

0.656

BMI (kg/m2)

23.51 ± 2.86

23.52 ± 2.56

0.517

SBP (mm Hg)

120.66 ± 11.79

121.64 ± 12.12

0.791

DBP (mm Hg)

73.05 ± 7.08

74.82 ± 6.93

0.153

FBG (mmol/L)

4.99 ± 0.87

5.11 ± 0.81

0.051

FINS (mIU/L)

9.22 ± 1.78

12.96 ± 2.15

0.000

HOMA-IR

2.02 ± 0.21

2.61 ± 0.37

0.000

LH (IU/L)

10.27 ± 2.26

16.02 ± 4.16

0.000

FSH (IU/L)

7.01 ± 2.04

10.22 ± 3.13

0.000

E2 (pmol/L)

171.16 ± 106.35

170.81 ± 104.34

0.756

T (µg/L)

0.63 ± 0.15

1.02 ± 0.30

0.000

PRL (µg/L)

13.80 ± 4.75

13.93 ± 5.59

0.891

P (nmol/L)

1.23 ± 0.51

1.06 ± 0.52

0.015

AMH (ng/mL)

6.86 ± 1.59

11.23 ± 2.01

0.000

TC (mmol/L)

4.85 ± 0.34

4.90 ± 0.35

0.261

TG (mmol/L)

0.91 ± 0.20

0.89 ± 0.23

0.279

HDL-C (mmol/L)

1.64 ± 0.11

1.62 ± 0.07

0.356

LDL-C (mmol/L)

2.59 ± 0.21

2.61 ± 0.26

0.217

  1. Abbreviations: PCOS: polycystic ovary syndrome; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; FINS: fasting insulin; LH: luteinizing hormone; FSH: follicle-stimulating hormone; E2: estradiol; T: testosterone; PRL: prolactin; P: progesterone; AMH: anti-mullerian hormone; HOMA-IR: homeostasis model assessment of insulin resistance; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol. Data are presented as mean ± standard deviation (SD).